Parkinsonís Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa

(MARCH 7, 2016) – Zambon S.p.A. and partner Newron Pharmaceuticals S.p.A. have announced the expansion of its European market by launching Xadago (safinamide) to treat mid- to late-stage Parkinson’s disease (PD) in Italy. The drug is already available in Switzerland, Germany, and Spain. Read more